We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Compare different evaluation approaches and choose an appropriate method.
Actions that trial sponsors should consider to build resilience into clinical trial design
Case studies from across the health and social care sector showing examples of good practice in preventing health problems from happening.
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
This is a qualitative study
How to use a cost consequence analysis to evaluate your digital health product.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
How to use an economic evaluation to evaluate your digital health product.
The Advisory Committee on Clinical Impact Awards (ACCIA) advises health ministers on the presentation of clinical impact awards to consultants working in the NHS. ACCIA is an advisory non-departmental public body, sponsored by the Department of Health and Social Care...
The MHRA has today launched a public consultation on the revised ICH guideline on Good Clinical Practice.
Helping public health practitioners conducting evaluations – identifying when it is possible and appropriate to evaluate.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use routinely collected data to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Helping public health practitioners conducting evaluations – choosing evaluation methods.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.